Advertisement

Young Scientists Award Lecture 1978: Studies on the Role of Acetylhydrazine in Isoniazid Hepatotoxicity

  • J. A. Timbrell
Part of the Archives of Toxicology book series (TOXICOLOGY, volume 2)

Abstract

Some factors affecting the metabolism of acetylhydrazine were studied in rats. This compound, a potent hepatotoxin, is a metabolite of isoniazid in man and is thought to be responsible for the hepatotoxicity of the drug. Isoniazid inhibited both the microsomal metabolism of acetylhydrazine, in vitro, and the acetylation to diacetylhydrazine in vivo.

The overall effect of isoniazid in vivo was to increase metabolism of acetyl-hydrazine through the microsomal pathway leading to increased covalent binding of the toxic reactive intermediate to liver protein. The results suggest that the metabolism of acetylhydrazine produced as a metabolite of isoniazid may be quantitatively different from the metabolism of the compound alone.

Preliminary studies in patients suffering isoniazid related liver damage indicated that acetylation of acetylhydrazine may be one of the factors involved in the hepatotoxicity of isoniazid in man.

Key words

Acetylhydrazine Isoniazid Acetylation Hepatotoxicity. 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Girling, D. J.: The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide. Tubercle 59, 13–32 (1978)PubMedCrossRefGoogle Scholar
  2. Jeffay, H., Alvarez, J.: Liquid scintillation counting of carbon-14. Analyt. Chem. 33, 612–615 (1961)CrossRefGoogle Scholar
  3. Jollow, D. J., Mitchell, J. R., Potter, W. Z., Davis, D. C., Gillette, J. R., Brodie, B. B.: Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J. Pharmacol. Exp. Ther. 187, 195–202 (1973)PubMedGoogle Scholar
  4. Kutt, H., Verebely, K., McDowell, F.: Inhibition of diphenylhydantoin metabolism in rats and in rat liver microsomes by antitubercular drugs. Neurology 18, 706–710 (1968)PubMedGoogle Scholar
  5. Mitchell, J. R., Thorgiersson, U. P., Black, M., Timbrell, J. A., Snodgrass, W. R., Potter, W. Z., Jollow, D. J., Keiser, H.: Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydrazine metabolites. Clin. Pharmacol. Ther. 18, 70–79 (1975)PubMedGoogle Scholar
  6. Mitchell, J. R., Zimmerman, H. J., Ishak, K. G., Thorgiersson, U. P., Timbrell, J. A., Snodgrass, W. R., Nelson, S. D.: Isoniazid liver injury: clinical spectrum, pathology and probable pathogenesis. Ann. Intern. Med. 84, 181–192 (1976)PubMedGoogle Scholar
  7. Nelson, S. D., Mitchell, J. R., Timbrell, J. A., Snodgrass, W. R., Corcoran, G. B.: Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat. Science 193, 901–903 (1976a)PubMedCrossRefGoogle Scholar
  8. Nelson, S. D., Hinson, J. A., Mitchell, J. R.: Application of chemical ionisation mass spectrometry and the twin-ion technique to better define a mechanism in acetylhydrazine toxicity. Biochem. Biophys. Res. Commun. 69, 900–907 (1976b)PubMedCrossRefGoogle Scholar
  9. Potter, W. Z., Davis, D. C., Mitchell, J. R., Jollow, D. J., Gillette, J. R., Brodie, B. B.: Acetaminophen-induced hepatic necrosis. III. cytochrome P-450-mediated covalent binding in vitro. J. Pharmacol. Exp. Ther. 187, 203–210 (1973)PubMedGoogle Scholar
  10. Timbrell, J. A., Mitchell, J. R., Snodgrass, W. R., Nelson, S. D.: Unpublished results (1976)Google Scholar
  11. Timbrell, J. A., Wright, J. M., Baillie, T. A.: Monoacetylhydrazine as a metabolite of isoniazid in man. Clin. Pharmacol. Ther. 22, 602–608 (1977a)PubMedGoogle Scholar
  12. Timbrell, J. A., Wright, J. M., Smith, C. M.: Determination of hydrazine metabolites of isoniazid in human urine by gas chromatography. J. Chromatogr. 138, 165–172 (1977b)PubMedCrossRefGoogle Scholar
  13. Wright, J. M., Timbrell, J. A.: Factors affecting the metabolism of [14C]-acetylhydrazine in rats. Drug Metab. Disp. 6, 561–566 (1978)Google Scholar

Copyright information

© Springer-Verlag 1979

Authors and Affiliations

  • J. A. Timbrell
    • 1
  1. 1.Clinical Toxicology Unit, Clinical Pharmacology Dept.Royal Postgraduate Medical SchoolLondon W12UK

Personalised recommendations